NVO

Novo Nordisk AS

141.85 USD
-0.11 (-0.08%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Novo Nordisk AS stock is up 4.27% since 30 days ago. The next earnings date is Aug 8, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 70.45% of the previous 43 June’s closed higher than May. In the last 10 Unusual Options Trades, there were 1 PUT, 9 CALLs. 100% of analysts rate it a buy.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
21 Jun 18:09 20 Sep, 2024 130.00 PUT 500 829
21 Jun 18:32 21 Mar, 2025 165.00 CALL 33 394
21 Jun 18:53 20 Dec, 2024 130.00 CALL 25 266
21 Jun 19:23 12 Jul, 2024 147.00 CALL 141 25
21 Jun 19:27 21 Jun, 2024 130.00 CALL 40 2530
21 Jun 19:36 20 Sep, 2024 165.00 CALL 155 475
21 Jun 19:36 21 Jun, 2024 130.00 CALL 178 2530
21 Jun 19:36 20 Sep, 2024 165.00 CALL 200 475
21 Jun 19:41 21 Jun, 2024 105.00 CALL 20 1019
21 Jun 19:52 21 Jun, 2024 125.00 CALL 50 2141

About Novo Nordisk AS

Novo Nordisk A/S engages in the research, development, manufacture, and marketing of pharmaceutical products. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in areas of haemophilia, growth disorders, and hormone replacement therapy. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

  • Cantor Fitzgerald
    Thu Jun 20, 13:01
    buy
    confirm
  • Cantor Fitzgerald
    Mon Jun 17, 13:24
    buy
    confirm
  • Argus Research
    Mon Jun 10, 08:43
    buy
    confirm